Health & Fitness
Mon, April 11, 2011Sun, April 10, 2011Sat, April 9, 2011Fri, April 8, 2011Thu, April 7, 2011Wed, April 6, 2011Tue, April 5, 2011Mon, April 4, 2011Sun, April 3, 2011Sat, April 2, 2011Fri, April 1, 2011Thu, March 31, 2011Wed, March 30, 2011Tue, March 29, 2011Mon, March 28, 2011Sun, March 27, 2011Fri, March 25, 2011Thu, March 24, 2011Wed, March 23, 2011Tue, March 22, 2011Mon, March 21, 2011Sun, March 20, 2011Fri, March 18, 2011Thu, March 17, 2011The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Cardio
Published in Health and Fitness on Wednesday, March 30th 2011 at 10:05 GMT by Market Wire
NEW YORK--([ BUSINESS WIRE ])--Levi & Korsinsky is investigating the Board of Directors of Cardiogenesis Corporation (aCardiogenesisa or the aCompanya) (OTC: CGCP) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to CryoLife, Inc. (NYSE: CRY). Under the terms of the transaction, Cardiogenesis shareholders will receive $0.457 in cash per share of Cardiogenesis stock they own, for a total transaction value of $22 million. If over 83.5 percent of the outstanding shares of Cardiogenesis are tendered in the tender offer, CryoLife expects to exercise a atop upa option and will close on the short-form merger approximately 10 days thereafter.
Click here to learn how to join the action: [ http://www.zlk.com/cardiogenesis-corporation-cgcp.html ], or call: 877-363-5972.
The investigation concerns whether the Cardiogenesis Board of Directors breached their fiduciary duties to Cardiogenesis stockholders by failing to adequately shop the Company before entering into this transaction and whether CryoLife, Inc. is underpaying for Cardiogenesis shares, thus unlawfully harming Cardiogenesis stockholders. In particular, at least one analyst set a price target of $6.00 per share of Cardiogenesis stock.
If you own common stock in Cardiogenesis and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at [ jlevi@zlk.com ] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit [ http://www.zlk.com/cardiogenesis-corporation-cgcp.html ].
Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 15th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
[ www.zlk.com ]
